197 related articles for article (PubMed ID: 30509670)
1. Could FA-PG-SPIONs act as a hyperthermia sensitizing agent? An in vitro study.
Fakhimikabir H; Tavakoli MB; Zarrabi A; Amouheidari A; Rahgozar S
J Therm Biol; 2018 Dec; 78():73-83. PubMed ID: 30509670
[TBL] [Abstract][Full Text] [Related]
2. The role of folic acid-conjugated polyglycerol coated iron oxide nanoparticles on radiosensitivity with clinical electron beam (6 MeV) on human cervical carcinoma cell line: In vitro study.
Fakhimikabir H; Tavakoli MB; Zarrabi A; Amouheidari A; Rahgozar S
J Photochem Photobiol B; 2018 May; 182():71-76. PubMed ID: 29626804
[TBL] [Abstract][Full Text] [Related]
3. Lomustine Loaded Superparamagnetic Iron Oxide Nanoparticles Conjugated with Folic Acid for Treatment of Glioblastoma Multiforma (GBM).
Jafari S; Tavakoli MB; Zarrabi A
Iran J Pharm Res; 2020; 19(2):134-144. PubMed ID: 33224218
[TBL] [Abstract][Full Text] [Related]
4. Biocompatible superparamagnetic core-shell nanoparticles for potential use in hyperthermia-enabled drug release and as an enhanced contrast agent.
Patil-Sen Y; Torino E; De Sarno F; Ponsiglione AM; Chhabria V; Ahmed W; Mercer T
Nanotechnology; 2020 Sep; 31(37):375102. PubMed ID: 32392545
[TBL] [Abstract][Full Text] [Related]
5. LyP-1-conjugated Fe
Teo P; Wang X; Zhang J; Zhang H; Yang X; Huang Y; Tang J
J Biomater Sci Polym Ed; 2018 Feb; 29(2):181-194. PubMed ID: 29165044
[TBL] [Abstract][Full Text] [Related]
6. Investigation of Combination Effect Between 6 MV X-Ray Radiation and Polyglycerol Coated Superparamagnetic Iron Oxide Nanoparticles on U87-MG Cancer Cells.
S J; M C; M B T; A Z; K GS; R A
J Biomed Phys Eng; 2020 Feb; 10(1):15-24. PubMed ID: 32158708
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy.
Thomas RG; Moon MJ; Lee H; Sasikala AR; Kim CS; Park IK; Jeong YY
Carbohydr Polym; 2015 Oct; 131():439-46. PubMed ID: 26256205
[TBL] [Abstract][Full Text] [Related]
8. Dual-responsive polymer coated superparamagnetic nanoparticle for targeted drug delivery and hyperthermia treatment.
Patra S; Roy E; Karfa P; Kumar S; Madhuri R; Sharma PK
ACS Appl Mater Interfaces; 2015 May; 7(17):9235-46. PubMed ID: 25893447
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of actively targetable superparamagnetic nanoparticles to the folate receptor positive cancer cells.
Nasiri R; Hamzehalipour Almaki J; Idris AB; Abdul Majid FA; Nasiri M; Salouti M; Irfan M; Amini N; Marvibaigi M
Mater Sci Eng C Mater Biol Appl; 2016 Dec; 69():1147-58. PubMed ID: 27612812
[TBL] [Abstract][Full Text] [Related]
10. High-frequency, magnetic-field-responsive drug release from magnetic nanoparticle/organic hybrid based on hyperthermic effect.
Hayashi K; Ono K; Suzuki H; Sawada M; Moriya M; Sakamoto W; Yogo T
ACS Appl Mater Interfaces; 2010 Jul; 2(7):1903-11. PubMed ID: 20568697
[TBL] [Abstract][Full Text] [Related]
11. Biotechnological approach to induce human fibroblast apoptosis using superparamagnetic iron oxide nanoparticles.
Ferraz FS; López JL; Lacerda SMSN; Procópio MS; Figueiredo AFA; Martins EMN; Guimarães PPG; Ladeira LO; Kitten GT; Dias FF; Domingues RZ; Costa GMJ
J Inorg Biochem; 2020 May; 206():111017. PubMed ID: 32120160
[TBL] [Abstract][Full Text] [Related]
12. 2-Deoxy-D-Glucose Modified Magnetic Nanoparticles with Dual Functional Properties: Nanothermotherapy and Magnetic Resonance Imaging.
Zhao L; Zheng Y; Yan H; Xie W; Sun X; Li N; Tang J
J Nanosci Nanotechnol; 2016 Mar; 16(3):2401-7. PubMed ID: 27455648
[TBL] [Abstract][Full Text] [Related]
13. Triple Therapy of HER2
Zolata H; Afarideh H; Davani FA
Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles on BT-474 human breast cancer cell viability.
Aliakbari M; Mohammadian E; Esmaeili A; Pahlevanneshan Z
Toxicol In Vitro; 2019 Feb; 54():114-122. PubMed ID: 30266435
[TBL] [Abstract][Full Text] [Related]
15. Efficient treatment of breast cancer xenografts with multifunctionalized iron oxide nanoparticles combining magnetic hyperthermia and anti-cancer drug delivery.
Kossatz S; Grandke J; Couleaud P; Latorre A; Aires A; Crosbie-Staunton K; Ludwig R; Dähring H; Ettelt V; Lazaro-Carrillo A; Calero M; Sader M; Courty J; Volkov Y; Prina-Mello A; Villanueva A; Somoza Á; Cortajarena AL; Miranda R; Hilger I
Breast Cancer Res; 2015 May; 17(1):66. PubMed ID: 25968050
[TBL] [Abstract][Full Text] [Related]
16. Polymeric liposomes-coated superparamagnetic iron oxide nanoparticles as contrast agent for targeted magnetic resonance imaging of cancer cells.
Liao Z; Wang H; Lv R; Zhao P; Sun X; Wang S; Su W; Niu R; Chang J
Langmuir; 2011 Mar; 27(6):3100-5. PubMed ID: 21341768
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic evaluation of magnetic hyperthermia using Fe3O4-aminosilane-coated iron oxide nanoparticles in glioblastoma animal model.
Rego GNA; Mamani JB; Souza TKF; Nucci MP; Silva HRD; Gamarra LF
Einstein (Sao Paulo); 2019 Aug; 17(4):eAO4786. PubMed ID: 31390427
[TBL] [Abstract][Full Text] [Related]
18. 90Y-CA/SPIONs for dual magnetic hyperthermia-radionuclide nanobrachytherapy of solid tumours.
Vukadinović A; Milanović Z; Ognjanović M; Janković D; Radović M; Mirković M; Karageorgou MA; Bouziotis P; Erić S; Vranješ-Đurić S; Antić B; Prijović Ž
Nanotechnology; 2022 Jul; 33(40):. PubMed ID: 35728572
[TBL] [Abstract][Full Text] [Related]
19. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
20. Efficient MRI labeling of endothelial progenitor cells: design of thiolated surface stabilized superparamagnetic iron oxide nanoparticles.
Shahnaz G; Kremser C; Reinisch A; Vetter A; Laffleur F; Rahmat D; Iqbal J; Dünnhaupt S; Salvenmoser W; Tessadri R; Griesser U; Bernkop-Schnürch A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):346-55. PubMed ID: 23481176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
